Two Sigma Advisers’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,596,900
Closed -$8.05M 896
2025
Q4
$8.05M Buy
2,596,900
+726,800
+39% +$2.07M 0.02% 618
2025
Q3
$4.92M Buy
1,870,100
+197,900
+12% +$436K 0.01% 754
2025
Q2
$2.06M Buy
1,672,200
+385,000
+30% +$420K ﹤0.01% 1108
2025
Q1
$1.42M Buy
1,287,200
+129,700
+11% +$150K ﹤0.01% 1295
2024
Q4
$1.05M Buy
1,157,500
+357,500
+45% +$306K ﹤0.01% 1438
2024
Q3
$789K Sell
800,000
-23,900
-3% -$23K ﹤0.01% 1515
2024
Q2
$742K Sell
823,900
-336,800
-29% -$252K ﹤0.01% 1708
2024
Q1
$1.37M Buy
1,160,700
+59,900
+5% +$65.9K ﹤0.01% 1417
2023
Q4
$1M Buy
1,100,800
+47,400
+4% +$35K ﹤0.01% 1648
2023
Q3
$877K Sell
1,053,400
-649,500
-38% -$748K ﹤0.01% 1578
2023
Q2
$2.04M Sell
1,702,900
-137,500
-7% -$171K 0.01% 1191
2023
Q1
$2.32M Buy
1,840,400
+15,700
+0.9% +$30.1K 0.01% 1198
2022
Q4
$3.96M Buy
1,824,700
+957,000
+110% +$7.88M 0.01% 875
2022
Q3
$10.4M Buy
867,700
+562,600
+184% +$6.98M 0.03% 492
2022
Q2
$2.55M Buy
305,100
+7,300
+2% +$56.6K 0.01% 1087
2022
Q1
$2.58M Buy
297,800
+32,600
+12% +$314K 0.01% 1107
2021
Q4
$3M Buy
265,200
+61,600
+30% +$732K 0.01% 995
2021
Q3
$2.56M Sell
203,600
-155,100
-43% -$1.43M 0.01% 1118
2021
Q2
$2.91M Sell
358,700
-131,500
-27% -$1.14M 0.01% 1117
2021
Q1
$4.53M Buy
490,200
+289,400
+144% +$2.92M 0.01% 888
2020
Q4
$1.94M Buy
200,800
+50,100
+33% +$493K 0.01% 1278
2020
Q3
$1.87M Buy
150,700
+97,000
+181% +$1.29M 0.01% 1195
2020
Q2
$698K Buy
+53,700
New +$675K ﹤0.01% 1746

Other funds holding GOSS